Carregant...
Cerivastatin for lowering lipids
BACKGROUND: Cerivastatin was the most potent statin until it was withdrawn from the market due to a number of fatalities due to rhabdomyolysis, however, the dose‐related magnitude of effect of cerivastatin on blood lipids is not known. OBJECTIVES: Primary objective To quantify the effects of various...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2020
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984625/ https://ncbi.nlm.nih.gov/pubmed/31981471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012501.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|